BPA for xyrem

Ended Awarded Last action

Contract number
VA797P16A0014
Awardee
Awarding agency
Task orders
7 $709,768 obligated

Award facts

Opportunity
  • VA797P12Q0002 Solicitation number
Combined order value
$709,768 Current and potential, with all options
Last date to order 100% complete
Award type
Single award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

The Department of Veterans Affairs (VA) awarded a Blanket Purchase Agreement (BPA) under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) to Jazz Pharmaceuticals, Inc., a global biopharmaceutical company, to provide specialty pharmaceutical products such as Xyrem, Xywav, and sodium oxybate formulations. The BPA, valued at up to $150 million, allows the VA to efficiently procure needed medications to support healthcare services for veterans at VA medical facilities nationwide. Multiple call orders have been placed against the BPA, totaling over $717,000, to deliver Xyrem to VA locations in California, Maine, and other regions. As the prime contractor, Jazz Pharmaceuticals has also provided over $3 million in prescription medications, including Xyrem, Xywav, and sodium oxybate, to VA networks in California, Missouri, and Oregon between 2019 and 2023 through this contract vehicle. The firm fixed price task orders were awarded by VA Integrated Service Networks to supply treatments for sleep disorders and other conditions served by VA medical centers and clinics. No set-asides were used in this procurement.

Task orders

Transactions

Action Obligated Date
Legal Contract Cancellation P00007 · BPA for xyrem cancelled $0
Exercise an Option P00006 · Exercise third option year for VA797P-16-a-0014 for xyrem $0
Supplemental Agreement for work within scope P00005 · 2019 public law updates $0
Exercise an Option P00004 · Exercise option year 2 $0
Supplemental Agreement for work within scope P00003 · 2018 public law updates $0
Exercise an Option P00002 · Option year 1 $0
Supplemental Agreement for work within scope P00001 · 2017 public law update for xyrem $0
Original award $0

Quick answers

Who was awarded contract VA797P16A0014?

VA797P16A0014 was awarded to Jazz Pharmaceuticals, Inc. by National Acquisition Center (Headquarters) on April 1, 2016.

How much is contract VA797P16A0014 worth?

Orders under VA797P16A0014 have obligated $709,768.

How many orders have been placed under contract VA797P16A0014?

7 orders have been placed under VA797P16A0014, the latest on January 15, 2019.

Who can order from contract VA797P16A0014?

VA797P16A0014 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.

Is contract VA797P16A0014 under another contract?

Yes. VA797P16A0014 is a blanket purchase agreement under V797P5131B, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract VA797P16A0014 competed?

The extent of competition for VA797P16A0014 was full and open competition. The government received 1 offer.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV